Company: Intuitive Surgical, Inc.
Ticker: ISRG
Form: 10-K
Filed: 2026-02-03
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Intuitive Surgical, Inc.'s operating cash flow margin in fiscal year 2025?
Question Type: derived_ratio

Concept: NetCashProvidedByUsedInOperatingActivities
RevenueFromContractWithCustomerExcludingAssessedTax
Answer (Numeric): 30.11
Answer (Display): 30.11%
Unit: percent

Evidence:
[{"chunk_id": "295", "equivalent_chunk_ids": ["295"], "section": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "supports": ["numerator", "denominator"], "text": "(IN MILLIONS)\nYear Ended December 31,\nOperating activities:\nNet income\n2,876.6\n2,337.5\n1,817.3\nAdjustments to reconcile net income to net cash provided by operating activities:\nDepreciation and loss on disposal of property, plant, and equipment, net\n614.7\n445.3\n401.6\nAmortization of intangible and other assets\n62.4\n54.4\n53.2\nGain on sale of business\n(Gain) loss on investments and (accretion) amortization of investment discounts and premiums, net\n57.2\n43.3\nDeferred income taxes\n19.1\n135.3\n280.8\nShare-based compensation expense\n788.2\n676.8\n592.8\nChanges in operating assets and liabilities, net of effects of acquisitions:\nAccounts receivable\n301.7\n95.9\n186.3\nInventory\n1,063.4\n830.0\n712.5\nPrepaids and other assets\n187.1\n231.8\n24.2\nAccounts payable\n57.9\n41.7\nAccrued compensation and employee benefits\n112.7\n99.3\n34.8\nDeferred revenue\n75.2\n31.2\n53.4\nOther liabilities\n34.1\n108.3\n32.9\nNet cash provided by operating activities\n3,030.5\n2,415.0\n1,813.8\nInvesting activities:\nPurchases of investments\n1,215.9\n5,139.6\n2,207.4\nProceeds from sales of investments\n259.9\n100.2\n230.3\nProceeds from maturities of investments\n2,175.5\n2,878.8\n2,690.1\nPurchases of property, plant, and equipment\n539.8\n1,111.2\n1,064.2\nAcquisition of businesses, net of cash, and intellectual property and other investing activities\n13.9\nNet cash provided by (used in) investing activities\n665.8\n3,272.8\n360.1\nFinancing activities:\nProceeds from issuance of common stock relating to employee stock plans\n350.3\n429.4\n296.3\nTaxes paid related to net share settlement of equity awards\n419.1\n270.0\n164.7\nRepurchases of common stock\n2,295.3\n416.3\nCash dividends paid by joint venture to noncontrolling interest\nPayment of deferred purchase consideration\nNet cash provided by (used in) financing activities\n2,364.1\n150.9\n287.6\nEffect of exchange rate changes on cash, cash equivalents, and restricted cash\n12.8\nNet increase (decrease) in cash, cash equivalents, and restricted cash\n1,345.0\n707.7\n1,169.4\nCash, cash equivalents, and restricted cash, beginning of year\n2,062.4\n2,770.1\n1,600.7\nCash, cash equivalents, and restricted cash, end of year\n3,407.4\n2,062.4\n2,770.1\nThe accompanying notes are an integral part of these Consolidated Financial Statements.\nINTUITIVE SURGICAL, INC.\nNOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS\nIn this report, “Intuitive,” the “Company,” “we,” “us,” and “our” refer to Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries.\nNOTE 1.\nDESCRIPTION OF THE BUSINESS"}]

Derivation: {"denominator": "revenue", "denominator_value": 10064.7, "format": "percentage", "numerator": "operating_cash_flow", "numerator_value": 3030.5, "op": "divide"}